From: A combination of the activation marker CD86 and the immune checkpoint marker B and T lymphocyte attenuator (BTLA) indicates a putative permissive activation state of B cell subtypes in healthy blood donors independent of age and sex
Antigen specificity
Clone name
Fluorochrome
Vendor
CD272 (BTLA)
564,802
BV421
BDa
CD86
566,131
BV480
BD
IgD
555,778
FITC
CD24
555,428
PE
CD19
561,295
PerCP-Cy5.5
CD27
560,609
PE-Cy7
CD38
555,462
APC
CD20
560,734
APC-H7